JMP Securities Downgrades Infinity Pharmaceutical (INFI) to Market Perform
Tweet
Share
E-mailGet Alerts INFI Hot Sheet
Price: $0.04 --0%
Rating Summary:
12 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 60
Rating Summary:
12 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 60
Join SI Premium – FREE
JMP Securities downgraded Infinity Pharmaceutical (NASDAQ: INFI) from Market Outperform to Market Perform.
For an analyst ratings summary and ratings history on Infinity Pharmaceutical click here. For more ratings news on Infinity Pharmaceutical click here.
Shares of Infinity Pharmaceutical closed at $1.36 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Downgrades Papa John\'s (PZZA) to Underperform, 'Management turnover increases NT uncertainty'
- Loop Capital Downgrades Best Buy (BBY) to Hold
- CLSA Downgrades Krung Thai Bank PCL (KTB:TB) to Outperform (2)
Create E-mail Alert Related Categories
DowngradesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
